← back to search

Timothy R. Smith

Harvard University · US
Area of research
Genetics · Epidemiology
Research interest
Research interests include Glioma Diagnosis and Treatment, Meningioma and schwannoma management, Pituitary Gland Disorders and Treatments, and Brain Metastases and Treatment.
h-index
56
citations
12,057
works
498
NIH funding
primary concept
Medicine
email

Recent publications

Impact of Extent of Resection on Survival in Brain Metastasis: An Analysis of 867 Patients
Neurosurgery 2025cited by 2position: middledoi
Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms
International Journal of Molecular Sciences 2024cited by 30position: middledoi
The Case for Neurosurgical Intervention in Cancer Neuroscience
Neurosurgery 2024cited by 6position: middledoi
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity
JAMA 2023cited by 657position: middledoi
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma
Journal of Clinical Oncology 2023cited by 161position: middledoi
Artificial Intelligence in Neurosurgery: A State-of-the-Art Review from Past to Future
Diagnostics 2023cited by 73position: middledoi
Defining benchmark outcomes for transsphenoidal surgery of pituitary adenomas: a multicenter analysis
European Journal of Endocrinology 2023cited by 14position: middledoi
Traditional Machine Learning Methods versus Deep Learning for Meningioma Classification, Grading, Outcome Prediction, and Segmentation: A Systematic Review and Meta-Analysis
World Neurosurgery 2023cited by 13position: middledoi
A Multicenter, Propensity Score–Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas
Neurosurgery 2023cited by 13position: middledoi
The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: An international multicenter report
Clinical Neurology and Neurosurgery 2023cited by 9position: middledoi
Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study
The Lancet Oncology 2022cited by 88position: middledoi
Impact of maximal extent of resection on postoperative deficits, patient functioning, and survival within clinically important glioblastoma subgroups
Neuro-Oncology 2022cited by 57position: middledoi
Tumor-Associated Macrophages/Microglia in Glioblastoma Oncolytic Virotherapy: A Double-Edged Sword
International Journal of Molecular Sciences 2022cited by 31position: middledoi
Complications and cosmetic outcomes of materials used in cranioplasty following decompressive craniectomy—a systematic review, pairwise meta-analysis, and network meta-analysis
Acta Neurochirurgica 2022cited by 26position: lastdoi
Statins and Gliomas: A Systematic Review of the Preclinical Studies and Meta-Analysis of the Clinical Literature
Drugs 2022cited by 16position: middledoi
Passive Data Use for Ethical Digital Public Health Surveillance in a Postpandemic World.
2022cited by 9position: contributordoi
Hajek and Hirsch: Otolaryngology Pioneers of Endonasal Transsphenoidal Pituitary Surgery
The Laryngoscope 2022cited by 7position: middledoi
Classification of glioblastoma versus primary central nervous system lymphoma using convolutional neural networks
Scientific Reports 2021cited by 50position: middledoi
Surgical and Peri-Operative Considerations for Brain Metastases
Frontiers in Oncology 2021cited by 29position: middledoi
Passive Data Use for Ethical Digital Public Health Surveillance in a Postpandemic World (Preprint)
2021cited by 0position: contributordoi
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
Clinical Cancer Research 2020cited by 251position: middledoi
Subtype switching in breast cancer brain metastases: a multicenter analysis
Neuro-Oncology 2020cited by 112position: middledoi
Survival prediction of glioblastoma patients—are we there yet? A systematic review of prognostic modeling for glioblastoma and its clinical potential
Neurosurgical Review 2020cited by 56position: middledoi
Neurological toxicities associated with chimeric antigen receptor T-cell therapy
Brain 2019cited by 245position: middledoi
Glioma incidence and survival variations by county‐level socioeconomic measures
Cancer 2019cited by 117position: middledoi
Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis
Acta Neurochirurgica 2018cited by 114position: middledoi
Phase II study of pembrolizumab or pembrolizumab plus bevacizumab for recurrent glioblastoma (rGBM) patients.
Journal of Clinical Oncology 2018cited by 57position: middledoi
The survival effect of valproic acid in glioblastoma and its current trend: a systematic review and meta-analysis
Clinical Neurology and Neurosurgery 2018cited by 32position: lastdoi
Machine Learning and Neurosurgical Outcome Prediction: A Systematic Review
World Neurosurgery 2017cited by 460position: middledoi
Natural and Artificial Intelligence in Neurosurgery: A Systematic Review
Neurosurgery 2017cited by 256position: lastdoi

Grants

Intermediate Energy Physics at Dartmouth
NSF0244861$10,0002003–2005PIRePORTER

Frequent collaborators

Marike L. D. Broekman · Leiden University Medical Center14 papers (2017–2025)Rania A. Mekary · Social Change and Development8 papers (2017–2023)Omar Arnaout · Brigham and Women's Hospital7 papers (2017–2024)William B. Gormley · Neurological Surgery7 papers (2017–2021)David J. Coté · Neurological Surgery6 papers (2017–2022)Joeky T. Senders · Utrecht University5 papers (2017–2020) · 4 papers (2020–2025) · 4 papers (2022–2024)Aditya V. Karhade · Neurological Surgery3 papers (2017–2017)Florian Geßler · University of Rostock3 papers (2022–2024)Vasileios K. Kavouridis · Harvard University3 papers (2018–2025)Joshua D. Bernstock · University of Alabama at Birmingham3 papers (2022–2024)Pierpaolo Peruzzi · The Ohio State University3 papers (2022–2024)Charissa Jessurun · Harvard University3 papers (2022–2025)Ivo S. Muskens · University of Southern California3 papers (2017–2018)Koen Pepijn Pruijn · Medisch Centrum Haaglanden2 papers (2022–2022)Steven De Vleeschouwer · Antwerp University Hospital2 papers (2022–2022)Thomas Kaley · Vanderbilt-Ingram Cancer Center2 papers (2018–2020)Howard Colman · University of Utah2 papers (2018–2020)Djaina Satoer · Erasmus MC2 papers (2022–2022)